DHEA Against Vaginal Atrophy - Safety Study of 12 Months

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
The purpose of this Phase III trial is to assess the long-term safety of intravaginal dehydroepiandrosterone (DHEA) in non-hysterectomized postmenopausal women with vaginal atrophy aged 40 to 75 years.
Epistemonikos ID: 9e81b7ab027d3c6806405db772e47f0cc864ec6b
First added on: May 06, 2024